-
-
-
-
-
-
-
Jefferies on Inhibikase Therapeutics Inc (IKT): 'the stock at $200-250M cap is inexpensive'
-
-
-
-
-
-
-
Inhibikase Therapeutics (IKT) Misses Q1 EPS by 15c
-
-
-
-
-
-
-
Inhibikase Therapeutics Inc (IKT) PT Lowered to $5 at H.C. Wainwright
-
-
416,844 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

